People

Mathieu Choné is explicitly named by Porsolt in its2026 scientific research announcements. The published affiliation concerns preclinical pharmacology, safety assessment or neurotoxicity research. This records a source-qualified research contribution rather than inferring an executive title, outside clinical practice or an unpublished employment contract. A fuller individual career biography and authentic portrait were not verified in accessible primary material.